Holen Sie sich die Stockscreener-App
0.3371
1.27%
-0.0091
Schlusskurs vom Vortag:
$0.3462
Offen:
$0.3345
24-Stunden-Volumen:
434.16K
Relative Volume:
0.19
Marktkapitalisierung:
$8.61M
Einnahmen:
$476.00K
Nettoeinkommen (Verlust:
$-38.52M
KGV:
-0.3729
EPS:
-0.9041
Netto-Cashflow:
$-39.89M
1W Leistung:
-2.98%
1M Leistung:
-8.19%
6M Leistung:
-75.05%
1J Leistung:
-88.57%
1-Tages-Spanne:
$0.3321
$0.346
1-Wochen-Bereich:
$0.331
$0.389
52-Wochen-Spanne:
$0.2805
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Vergleichen Sie VYNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3382 | 8.82M | 476.00K | -38.52M | -39.89M | -0.9041 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.57 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.46 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.43 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.70 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.19 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Is VYNE Therapeutics Inc. stock undervalued vs historical averagesJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com
Will VYNE Therapeutics Inc. stock maintain momentum in 2025Earnings Beat & Risk Managed Investment Entry Signals - newser.com
Why analysts remain bullish on VYNE Therapeutics Inc. stockWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
What high frequency data says about VYNE Therapeutics Inc.Portfolio Gains Summary & Safe Entry Zone Identification - newser.com
Healthy Upside Potential: VYNE Therapeutics Inc (VYNE) - setenews.com
Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Declines By 29.5% - Defense World
Can swing trading help recover from VYNE Therapeutics Inc. losses2025 Price Action Summary & High Return Trade Guides - newser.com
What Wall Street predicts for VYNE Therapeutics Inc. stock price2025 Institutional Moves & Free Daily Entry Point Trade Alerts - newser.com
What earnings revisions data tells us about VYNE Therapeutics Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Why VYNE Therapeutics Inc. stock could be next big winnerJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Vyne Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Signal strength of VYNE Therapeutics Inc. stock in tech scanners2025 Earnings Surprises & Safe Entry Point Alerts - newser.com
Tools to monitor VYNE Therapeutics Inc. recovery probabilityWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
Understanding VYNE Therapeutics Inc.’s price movementTrade Signal Summary & Consistent Return Strategy Ideas - newser.com
Can technical indicators confirm VYNE Therapeutics Inc.’s reversalJuly 2025 Action & Pattern Based Trade Signal System - newser.com
Why VYNE Therapeutics Inc. stock is seen as undervaluedProfit Target & Consistent Return Investment Signals - newser.com
Is VYNE Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Using R and stats models for VYNE Therapeutics Inc. forecastingJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Is VYNE Therapeutics Inc. showing signs of accumulationTrade Ideas & Verified Stock Trade Ideas - newser.com
Will VYNE Therapeutics Inc. stock benefit from sector rotationJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.53%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):